Braun T - Search Results

1

NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome.

Braun T, Carvalho G, Coquelle A, Vozenin MC, Lepelley P, Hirsch F, Kiladjian JJ, Ribrag V, Fenaux P, Kroemer G. Braun T, et al. Blood. 2006 Feb 1;107(3):1156-65. doi: 10.1182/blood-2005-05-1989. Epub 2005 Oct 13. Blood. 2006. PMID: 16223780 Free article.

2

PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor.

Gonzalez-Polo RA, Carvalho G, Braun T, Decaudin D, Fabre C, Larochette N, Perfettini JL, Djavaheri-Mergny M, Youlyouz-Marfak I, Codogno P, Raphael M, Feuillard J, Kroemer G. Gonzalez-Polo RA, et al. Among authors: braun t. Oncogene. 2005 Nov 17;24(51):7503-13. doi: 10.1038/sj.onc.1208907. Oncogene. 2005. PMID: 16091749

3

Enrichment of non-synchronized cells in the G1, S and G2 phases of the cell cycle for the study of apoptosis.

Coquelle A, Mouhamad S, Pequignot MO, Braun T, Carvalho G, Vivet S, Métivier D, Castedo M, Kroemer G. Coquelle A, et al. Among authors: braun t. Biochem Pharmacol. 2006 Nov 30;72(11):1396-404. doi: 10.1016/j.bcp.2006.04.014. Epub 2006 Apr 29. Biochem Pharmacol. 2006. PMID: 16765323

4

Differentiating megakaryocytes in myelodysplastic syndromes succumb to mitochondrial derangement without caspase activation.

Braun T, Carvalho G, Grosjean J, Ades L, Fabre C, Boehrer S, Debili N, Fenaux P, Kroemer G. Braun T, et al. Apoptosis. 2007 Jun;12(6):1101-8. doi: 10.1007/s10495-006-0030-z. Apoptosis. 2007. PMID: 17245643

5

Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study.

Boehrer S, Adès L, Braun T, Galluzzi L, Grosjean J, Fabre C, Le Roux G, Gardin C, Martin A, de Botton S, Fenaux P, Kroemer G. Boehrer S, et al. Among authors: braun t. Blood. 2008 Feb 15;111(4):2170-80. doi: 10.1182/blood-2007-07-100362. Epub 2007 Oct 9. Blood. 2008. PMID: 17925489 Free article.

6

Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia.

Braun T, Fenaux P. Braun T, et al. Br J Haematol. 2008 May;141(5):576-86. doi: 10.1111/j.1365-2141.2008.07099.x. Epub 2008 Apr 10. Br J Haematol. 2008. PMID: 18410457 Free article. Review.

7

Flt3 receptor inhibition reduces constitutive NFkappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.

Grosjean-Raillard J, Adès L, Boehrer S, Tailler M, Fabre C, Braun T, De Botton S, Israel A, Fenaux P, Kroemer G. Grosjean-Raillard J, et al. Among authors: braun t. Apoptosis. 2008 Sep;13(9):1148-61. doi: 10.1007/s10495-008-0243-4. Apoptosis. 2008. PMID: 18670883

8

Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases.

Braun T, de Botton S, Taksin AL, Park S, Beyne-Rauzy O, Coiteux V, Sapena R, Lazareth A, Leroux G, Guenda K, Cassinat B, Fontenay M, Vey N, Guerci A, Dreyfus F, Bordessoule D, Stamatoullas A, Castaigne S, Terré C, Eclache V, Fenaux P, Adès L. Braun T, et al. Leuk Res. 2011 Jul;35(7):863-7. doi: 10.1016/j.leukres.2011.02.008. Epub 2011 Mar 10. Leuk Res. 2011. PMID: 21396711

9

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial.

Braun T, Itzykson R, Renneville A, de Renzis B, Dreyfus F, Laribi K, Bouabdallah K, Vey N, Toma A, Recher C, Royer B, Joly B, Vekhoff A, Lafon I, Sanhes L, Meurice G, Oréar C, Preudhomme C, Gardin C, Ades L, Fontenay M, Fenaux P, Droin N, Solary E; Groupe Francophone des Myélodysplasies. Braun T, et al. Blood. 2011 Oct 6;118(14):3824-31. doi: 10.1182/blood-2011-05-352039. Epub 2011 Aug 9. Blood. 2011. PMID: 21828134 Free article. Clinical Trial.

10

Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM.

Natarajan-Amé S, Park S, Ades L, Vey N, Guerci-Bresler A, Cahn JY, Etienne G, Bordessoule D, Ravoet C, Legros L, Cheze S, Stamatoullas A, Berger E, Schmidt A, Charbonnier A, Chaury MP, Braun T, Fenaux P, Dreyfus F; Groupe Francophone des Myélodysplasies (GFM). Natarajan-Amé S, et al. Among authors: braun t. Br J Haematol. 2012 Jul;158(2):232-237. doi: 10.1111/j.1365-2141.2012.09153.x. Epub 2012 May 10. Br J Haematol. 2012. PMID: 22571447 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,673 results

Search Page

Filters